Overview

Postoperative Thrombosis Prevention in Patients With CD

Status:
Recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
Patients with Cushing disease was randomized to 2 groups. After surgery, the patients were managed with mechanical prevention or mechanical prevention plus anticoagulant drugs(LMWH followed by rivaroxaban), VTE was observed 24h, 5day, 4weeks and 12weeks after surgery.Bleeding events were also recorded.
Phase:
N/A
Details
Lead Sponsor:
Huashan Hospital
Collaborators:
Peking Union Medical College Hospital
West China Hospital
Treatments:
Rivaroxaban